RYAN NAKASONE: Open Payments
NPI 1043207459 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 44 payments from 15 companies in 2025. Trend: 2023 $4,576 · 2024 $3,511 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $277 |
| Medtronic, Inc. | 4 | $270 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $153 |
| SPR Therapeutics, Inc | 2 | $80 |
| Collegium Pharmaceutical, Inc. | 5 | $77 |
| Boston Scientific Corporation | 3 | $68 |
| Globus Medical, Inc. | 2 | $57 |
| IBSA Pharma Inc. | 3 | $48 |
| BIOTRONIK NRO, Inc. | 2 | $46 |
| Fidia Pharma USA Inc. | 2 | $36 |
Products named: INCEPTIV, QULIPTA, JOURNAVX, UBRELVY, SPRINT PNS System, Belbuca, Intracept, Senza.
Industry payments across CA — which companies pay providers there.
